The Application of Generic Machine Learning to New Data Environments Requires “Something More” to be Patent Eligible READ MORE
Federal Circuit Affirms Presumption of Separateness in Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al., C.A. No. 24-2351 (Fed. Cir. Mar. 14, 2025) READ MORE
Defend & Deduct: How the Federal Circuit’s Actavis Decision Changes Tax Implications for ANDA Filers READ MORE
Andrew Wasson speaking at AIPLA CLE Web Series: Hot Topics in Chemical & Biotech Patent Practice READ MORE
Richard Kurz to speak at the New York City Bar Association – 2025 Intellectual Property Institute READ MORE
Federal Circuit Limits Use of PTAB Unpatentability Rulings to Estop Patentees From Asserting Claims READ MORE
Leadership Council on Legal Diversity (LCLD) Selects Partner Kaitlin Farrell as a 2025 Fellow and Associates Mark Basanta and Conrad Stumpf as 2025 Pathfinders READ MORE
